Kore Private Wealth LLC Sorrento Therapeutics, Inc. Transaction History

Kore Private Wealth LLC

  • $554 Million
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$1.73 - $6.76 $64,532 - $252,161
-37,302 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.57 - $4.76 $63,132 - $191,409
-40,212 Reduced 51.88%
37,302 $69,000
Q2 2019

Aug 14, 2019
BUY
$2.67 - $4.38 $149,594 - $245,402
56,028 Added 260.77%
77,514 $207,000
Q1 2019

May 16, 2019
BUY
$1.86 - $5.94 $18,183 - $58,069
9,776 Added 83.48%
21,486 $102,000
Q4 2018

May 23, 2019
BUY
$2.01 - $4.24 $23,537 - $49,650
11,710 New
11,710 $28,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Kore Private Wealth LLC Portfolio

Follow Kore Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kore Private Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email